NovoCure Ltd (NVCR) - Financial and Strategic SWOT Analysis Review

April 2021 | 54 pages | ID: NF1D7229D933EN
GlobalData

Abstracts

NovoCure Ltd (NVCR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

NovoCure Ltd (NovoCure) develops and commercializes novel delivery systems for the treatment of cancers of brain and abdomen. Its proprietary Tumor Treating Fields (TTF) technology platform uses electric fields tuned to specific frequencies for disrupting the division solid tumor cancer cells. The company markets TTF-based delivery systems: Optune Lua for the treatment of malignant pleural mesothelioma; and Optune for the treatment of glioblastoma. Both of its marketed products are indicated in combination with standard chemotherapies. NovoCure is also advancing product development and clinical programs intended to improve the survival of patients with pancreatic cancer, brain metastases, ovarian cancer, liver cancer, gastric cancer, and non-small cell lung cancer. It has subsidiaries in Europe, the Middle East, Asia, and North America. NovoCure is headquartered in Saint Helier, Jersey, the UK.

NovoCure Ltd Key Recent Developments

Apr 01,2021: Novocure to Report First Quarter 2021 Financial Results
Feb 25,2021: Novocure reports fourth quarter and full year 2020 financial results and provides company update
Feb 08,2021: Novocure announces addition to its board of directors
Jan 11,2021: Novocure announces fourth quarter and full year 2020 preliminary net revenues and provides company update
Nov 19,2020: Novocure announces 43 presentations on tumor treating fields at Society for Neuro-Oncology 2020 Virtual Annual Meeting

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

NovoCure Ltd - Key Facts
NovoCure Ltd - Key Employees
NovoCure Ltd - Key Employee Biographies
NovoCure Ltd - Major Products and Services
NovoCure Ltd - History
NovoCure Ltd - Company Statement
NovoCure Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
NovoCure Ltd - Business Description
Geographical Segment: EMEA
Performance
Geographical Segment: Greater China
Performance
Geographical Segment: Japan
Performance
Geographical Segment: The US
Performance
R&D Overview
NovoCure Ltd - Corporate Strategy
NovoCure Ltd - SWOT Analysis
SWOT Analysis - Overview
NovoCure Ltd - Strengths
NovoCure Ltd - Weaknesses
NovoCure Ltd - Opportunities
NovoCure Ltd - Threats
NovoCure Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

NovoCure Ltd, Medical Equipment, Deals By Year, 2015 to YTD 2021
NovoCure Ltd, Medical Equipment, Deals By Type, 2015 to YTD 2021
NovoCure Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Apr 01, 2021: Novocure to Report First Quarter 2021 Financial Results
Feb 25, 2021: Novocure reports fourth quarter and full year 2020 financial results and provides company update
Feb 08, 2021: Novocure announces addition to its board of directors
Jan 11, 2021: Novocure announces fourth quarter and full year 2020 preliminary net revenues and provides company update
Nov 19, 2020: Novocure announces 43 presentations on tumor treating fields at Society for Neuro-Oncology 2020 Virtual Annual Meeting
Nov 10, 2020: Novocure announces agenda for Virtual Research and Development Day
Nov 02, 2020: Novocure announces proposed private placement of $500 million of convertible senior notes
Oct 29, 2020: Novocure reports third quarter 2020 financial results and provides company update
Oct 29, 2020: Novocure announces strategic alliance with NYU Grossman School of Medicine for preclinical and clinical Research
Aug 13, 2020: Novocure announces expansion of its executive leadership team

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

NovoCure Ltd, Key Facts
NovoCure Ltd, Key Employees
NovoCure Ltd, Key Employee Biographies
NovoCure Ltd, Major Products and Services
NovoCure Ltd, History
NovoCure Ltd, Subsidiaries
NovoCure Ltd, Key Competitors
NovoCure Ltd, Ratios based on current share price
NovoCure Ltd, Annual Ratios
NovoCure Ltd, Annual Ratios (Cont...1)
NovoCure Ltd, Interim Ratios
NovoCure Ltd, Medical Equipment, Deals By Year, 2015 to YTD 2021
NovoCure Ltd, Medical Equipment, Deals By Type, 2015 to YTD 2021
NovoCure Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

NovoCure Ltd, Performance Chart (2016 - 2020)
NovoCure Ltd, Ratio Charts
NovoCure Ltd, Medical Equipment, Deals By Year, 2015 to YTD 2021
NovoCure Ltd, Medical Equipment, Deals by Type, 2015 to YTD 2021